tirzepatide back on shortage list Semaglutide and off FDA list: What does this mean for weight loss drug access? US judge sides with FDA's

Wash hands thoroughly before handling peptides or injection supplies

Across the way, Mr

Nausea, fatigue, reduced appetite, and digestive changes are common

The report was uncontrolled, unblinded, not randomized, had no comparator arm, used patient-reported outcomes rather than validated pain instruments, and did not publish dose, effect size, confidence intervals, p-values, or systematically collected adverse events limitations that severely constrain any clinical inference

Strong initial sales of the Wegovy pill will set the tone for the success of the drug in 2026 and beyond, especially in light of an anticipated orforglipron approval in April